Leukemia clinical trials
1,638 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all leukemia studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting leukemia studies. A study counts once in each state where it has a site.
- Texas254
- New York220
- California212
- Ohio178
- Florida162
- Massachusetts142
- Pennsylvania132
- North Carolina130
- Illinois121
- Washington119
- Maryland115
- Tennessee107
Also in China (448), France (184), Italy (148), Spain (118), Germany (110), Australia (101), United Kingdom (99), Canada (81).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 153
- Phase 1316
- Phase 1 / Phase 2192
- Phase 2382
- Phase 2 / Phase 343
- Phase 399
- Phase 421
- No phase (devices, programs)204
- Observational328
Recently updated studies
Recruiting leukemia studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 2NCT06672146
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Ages 18 Years and over · Tucson, Arizona · Little Rock, Arkansas +117 more · National Cancer Institute (NCI)
- RecruitingObservationalNCT07898436
Menin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia
Ages 0 Years – 17 Years · Strasbourg, France · University Hospital, Strasbourg, France
- RecruitingPhase 2NCT06124157
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Ages 366 Days – 46 Years · Birmingham, Alabama · Phoenix, Arizona +137 more · National Cancer Institute (NCI)
- RecruitingPhase 2NCT06661915
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Ages 18 Years and over · Irvine, California · Orange, California +29 more · National Cancer Institute (NCI)
- RecruitingObservationalNCT00001778
Evaluation of Patients With HAM/TSP
Ages 18 Years – 120 Years · Bethesda, Maryland · National Institute of Neurological Disorders and Stroke (NINDS)
- RecruitingObservationalNCT06459024
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Ages 6 Years and over · Aachen, Germany · Greifswald, Germany +33 more · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- RecruitingPhase 1NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Ages 7 Months – 21 Years · Madison, Wisconsin · University of Wisconsin, Madison
- RecruitingPhase 3NCT06713837
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Ages 18 Years and over · Brno, Czechia · Hradec Králové, Czechia +42 more · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.